Antibiotics for brain abscesses in people with cyanotic congenital heart disease

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Lumbiganon, Pagakrong ^a   Chaikitpinyo, A ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b NONE

Author keywords

Anti bacterial agents *therapeutic use ; Brain abscess *drug therapy ; Cyanosis complications ; Heart defects, congenital * complications ; Humans

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; METRONIDAZOLE; PENICILLIN G;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; BACTEROIDES FRAGILIS; BLOOD TOXICITY; BRAIN ABSCESS; CLINICAL TRIAL; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYANOTIC HEART DISEASE; DRUG EFFICACY; DRUG MEGADOSE; EMBASE; HAEMOPHILUS; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; PANCYTOPENIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 44949168713     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004469.pub2     Document Type: Review

References (36)

1. Abdullah 2001 Abdullah J. Clinical presentation and outcome of brain abscess over the last 6 years in a community based neurosurgical service. Journal of Clinical Neuroscience 2001;8(1):18-22.
2. British Society 2000 Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. The rational use of antibiotics in the treatment of brain abscess. British Journal of Neurosurgery 2000;14(6):525-30.
3. Gonzalez-Garcia 1999 Gonzalez-Garcia J, Gelabert M, Pravos AG, Villa JMF. Intracranial collections of pus: A review of 100 cases. Revista de neurologia 1999;29:416-24.
4. Hirsch 1983 Hirsch JF, Roux FX, Sainte-Rose C, Renier D, Pierre-Kahn A. Brain abscess in childhood. A study of 34 cases treated by puncture and antibiotics. Childs Brain 1983;10(4):251-65.
5. Jansson 2004 Jansson AK, Enblad P, Sjolin J. Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. European Journal of Clinical Microbiology & Infectious Diseases 2004;23:7-14.
6. Lu 2002 Lu CH, Chang WN, Lin YC, Tsai NW, Liliang PC, Su TM, Rau CS, Tsai YD, Liang CL, Chang CJ, Lee PY, Chang HW, Wu JJ. Bacterial brain abscess: microbiological features, epidemiological trends and therapeutic outcomes. Quarterly Journal of Medicine 2002;95:501-9.
7. Mampalum 1988 Mampalum TJ, Resenblum ML. Trends in the management of bacterial brain abscesses: a review of 102 cases over 17 years. Neurosurgery 1988;23(4):451-8.
8. Seneviratne Rde 2003 Senevirantne Rde S, Navvasivayam P, Perera S, Wickremasinghe RS. Microbiology of cerebral abscess at the neurosurgical unit of the National Hospital of Sri Lanka. Ceylon Medical Journal 2003;48(1):14-6.
9. Yang 1981 Yang SY. Brain abscess: a review of 400 cases. Journal of Neurosurgery 1981;55:794-9.
10. Brewer 1975 Brewer NS, MacCarrty CS, Wellman WE. Brain abscess: a review of recent experience. Annals of Internal Medicine 1975;82:571-6.
11. De Louvois 1978 De Louvois J. The bacteriology and chemotherapy of brain abscess. Journal of Antimicrobial Chemotherapy 1978;4:395-413.
12. Deeks 1998 Deeks JJ, Bradburn MJ, Bilker W, Localio R, Berlin J. Much ado about nothing: meta-analysis for rare events. Sixth International Cochrane Colloquium; 1998 Oct 22-26; Baltimore, MD, USA. 1998.
13. Demets 1987 Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
14. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
15. Dickersin 1994 Dickersin K, Scherer R, Lefebve C. Identifying relevant studies for systematic reviews. British Medical Journal 1994;309:1286-91.
16. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997;315(7190):629-34.
17. Fischbein 1974 Fischbein CA, Rosenthal A, Fischer EG, Nadas AS, Welch K. Risk factors of brain abscess in patients with congenital heart disease. American Journal of Cardiology 1974;34:97-102.
18. Hollis 1999 Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. British Medical Journal 1999;319:670-4.
19. ICH-GCP 1997 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. CFR & ICH Guidelines. Vol. 1. Philadelphia: Barnett International/PAREXEL, 1997.
20. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
21. Jadavji 1985 Jadavji T, Humphreys RP, Prober CG. Brain abscesses in infants and children. Pediatric Infectious Diseases 1985;4:394-8.
22. Jimenez 1987 Jimenez JJ, Arimura GK, Abou-Khalil WH, Isildar M, Yunis AA. Chloramphenicol-induced bone marrow injury: possible role of bacterial metabolites of chloramphenicol. Blood 1987;70:1180-5.
23. Juni 2001 Juni P, Altman D, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. British Medical Journal 2001;323(7303):42-6.
24. Kagawa 1983 Kagawa M, Takeshita M, Yato S, Kitamura K. Brain abscess in congenital cyanotic heart disease. Journal of Neurosurgery 1983;58:913-7.
25. Kjaergard 2001 Kjaergard L-L, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135:982- 9.
26. Lefebvre 1996 Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium 20-24 Oct; Adelaide, Australia. 1996.
27. Mathisen 1997 Mathisen GE, Johnson JP. Brain abscess. Clinical Infectious Diseases 1997;25:763-81.
28. Matson 1961 Matson DD, Salam M. Brain abscess in congenital heart disease. Pediatrics 1961;27:772-89.
29. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
30. Prusty 1993 Prusty GK. Brain abscesses in cyanotic heart disease. Indian Journal of Pediatrics 1993;60:43-51.
31. Saez-Llorens 1989 Saez-Llorens XJ, Umana MA, Odio CM, McCracken GH Jr, Nelson JD. Brain abscess in infants and children. Pediatric Infectious Disease Journal 1989;8:449-58.
32. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
33. Sjolin 1991 Sjolin J, Eriksson N, Arneborn P. Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans. Antimicrobial Agents Chemotherapy 1991;35:2606-10.
34. Sjolin 1993 Sjolin J, Lilja A, Eriksson N, Arneborn P, Cars O. Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clinical Infectious Diseases 1993;17:857-63.
35. Takeshita 1997 Takeshita M, Kagawa M, Yato S, Izawa M, Onda h, Takakura K, et al. Current treatment of brain abscess in patients with congenital cyanotic heart disease. Neurosurgery 1997;41(6):1270-8.
36. Yamamoto 1993 Yamamoto M, Jimbo M, Ide M. Penetration of intravenous antibiotics into brain abscess. Neurosurgery 1993;33:44-9.